New Data Show Low Incidence Of Augmentation Of Restless Legs Syndrome With 5-Year Neupro(R) (Rotigotine) Treatment

New 5-year data from the longest prospective open-label Restless Legs Syndrome (RLS) study to date, show that Neupro® (rotigotine) demonstrated continued symptomatic clinical benefit with a...